Video

Dr. Robesti on Optimizing Patient Selection for Salvage Lymph Node Dissection in Prostate Cancer

Daniele Robesti, MD, discusses how to optimize patient selection for salvage lymph node dissection in prostate cancer.

Daniele Robesti, MD, second-year resident, Università Vita-Salute San Raffaele, discusses how to optimize patient selection for salvage lymph node dissection in prostate cancer.

Salvage lymph node dissection is a treatment option for patients with prostate cancer who have experienced recurrence, Robesti says. However, patients should be properly selected to undergo this kind of treatment, since there are several options for patients in this setting, and outcomes of salvage lymph node dissection can vary, Robesti adds.

Salvage lymph node dissection is a surgical treatment that is typically done after the radical prostatectomy, and patient selection is crucial, since the approach is associated with several comorbidities, Robesti explains. Ideal patients for salvage lymph node dissection are those who can maintain progression-free survival and avoid the administration of hormonal therapy, and these patients can have an improved quality of life and improved oncological outcomes, Robesti concludes.

Related Videos
 Rupesh Rajesh Kotecha, MD
David A. Braun, MD, PhD
Francine Foss, MD
Daniel E. Haggstrom, MD
Ami Umesh Badami, MD
Kenneth Shain, MD, PhD
Piotr Rutkowski, MD
Manali Kamdar, MD, of University of Colorado Anschutz School of Medicine
Janaki Neela Sharma, MD, assistant professor, clinical medicine, Genitourinary Medical Oncology, University of Miami Health Systems
Cindy Medina Pabon, MD, assistant professor, Sylvester Cancer Center, University of Miami; assistant lead, GI Cancer Clinical Research, Gastrointestinal Medical Oncology, University of Miami Health Systems